AAAAAA

   
Results: 1-14 |
Results: 14

Authors: Suputtamongkol, Y Newton, PN Angus, B Teja-Isavadharm, P Keeratithakul, D Rasameesoraj, M Pukrittayakamee, S White, NJ
Citation: Y. Suputtamongkol et al., A comparison of oral artesunate and artemether antimalarial bioactivities in acute falciparum malaria, BR J CL PH, 52(6), 2001, pp. 655-661

Authors: Paton, NI Angus, B Chaowagul, W Simpson, AJ Suputtamongkol, Y Elia, M Calder, G Milne, E White, NJ Griffen, GE
Citation: Ni. Paton et al., Protein and energy metabolism in chronic bacterial infection: studies in melioidosis, CLIN SCI, 100(1), 2001, pp. 101-110

Authors: Wuthiekanun, V Suputtamongkol, Y Simpson, AJH Kanaphun, P White, NJ
Citation: V. Wuthiekanun et al., Value of throat swab in diagnosis of melioidosis, J CLIN MICR, 39(10), 2001, pp. 3801-3802

Authors: Angus, BJ Smith, MD Suputtamongkol, Y Mattic, H Walsh, AL Wuthiekanun, V Chaowagul, W White, NJ
Citation: Bj. Angus et al., Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis (vol 49, pg 445, 2000), BR J CL PH, 50(2), 2000, pp. 183-191

Authors: Angus, BJ Smith, MD Suputtamongkol, Y Mattie, H Walsh, AL Wuthiekanun, V Chaowagul, W White, NJ
Citation: Bj. Angus et al., Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis, BR J CL PH, 49(5), 2000, pp. 445-452

Authors: Newton, P Suputtamongkol, Y Teja-Isavadharm, P Pukrittayakamee, S Navaratnam, V Bates, I White, N
Citation: P. Newton et al., Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria, ANTIM AG CH, 44(4), 2000, pp. 972-977

Authors: Suputtamongkol, Y Intaranongpai, S Smith, MD Angus, B Chaowagul, W Permpikul, C Simpson, JA Leelarasamee, A Curtis, L White, NJ
Citation: Y. Suputtamongkol et al., A double-blind placebo-controlled study of an infusion of lexipafant (platelet-activating factor receptor antagonist) in patients with severe sepsis, ANTIM AG CH, 44(3), 2000, pp. 693-696

Authors: Simpson, AJH Smith, MD Weverling, GJ Suputtamongkol, Y Angus, BJ Chaowagul, W White, NJ van Deventer, SJH Prins, JM
Citation: Ajh. Simpson et al., Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis, J INFEC DIS, 181(2), 2000, pp. 621-625

Authors: Sirisinha, S Anuntagool, N Dharakul, T Ekpo, P Wongratanacheewin, S Naigowit, P Petchclai, N Thamlikitkul, V Suputtamongkol, Y
Citation: S. Sirisinha et al., Recent developments in laboratory diagnosis of melioidosis, ACT TROP, 74(2-3), 2000, pp. 235-245

Authors: Chaowagul, W Simpson, AJH Suputtamongkol, Y Smith, MD Angus, BJ White, NJ
Citation: W. Chaowagul et al., A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis, CLIN INF D, 29(2), 1999, pp. 375-380

Authors: Simpson, AJH Suputtamongkol, Y Smith, MD Angus, BJ Rajanuwong, A Wuthiekanun, V Howe, PA Walsh, AL Chaowagul, W White, NJ
Citation: Ajh. Simpson et al., Comparison of imipenem and ceftazidime as therapy for severe melioidosis, CLIN INF D, 29(2), 1999, pp. 381-387

Authors: Suputtamongkol, Y Chaowagul, W Chetchotisakd, P Lertpatanasuwun, N Intaranongpai, S Ruchutrakool, T Budhsarawong, D Mootsikapun, P Wuthiekanun, V Teerawatasook, N Lulitanond, A
Citation: Y. Suputtamongkol et al., Risk factors for melioidosis and bacteremic melioidosis, CLIN INF D, 29(2), 1999, pp. 408-413

Authors: Chaowagul, W Simpson, AJH Suputtamongkol, Y White, NJ
Citation: W. Chaowagul et al., Empirical cephalosporin treatment of melioidosis, CLIN INF D, 28(6), 1999, pp. 1328-1328

Authors: Lertpatanasuwan, N Sermsri, K Petkaseam, A Trakulsomboon, S Thamlikitkul, V Suputtamongkol, Y
Citation: N. Lertpatanasuwan et al., Arabinose-positive Burkholderia pseudomallei infection in humans: Case report, CLIN INF D, 28(4), 1999, pp. 927-928
Risultati: 1-14 |